Wenjin Wang Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

1/2019

Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenjin Wang Research Topics

Disease

9	Ulcerative Colitis 01/2023 - 09/2019
6	Neoplasms (Cancer) 04/2024 - 01/2021
6	Squamous Cell Carcinoma of Head and Neck 04/2024 - 01/2021
4	Pain (Aches) 11/2023 - 11/2009
4	Carcinogenesis 01/2022 - 01/2021
4	Opioid-Induced Constipation 11/2011 - 11/2009
3	Infections 04/2024 - 12/2003
3	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2021
3	Oral Submucous Fibrosis 01/2022 - 09/2017
3	Crohn Disease (Crohn's Disease) 01/2019 - 09/2014
3	Gastroesophageal Reflux (GERD) 02/2011 - 10/2006
2	Chronic Disease (Chronic Diseases) 01/2023 - 12/2022
2	Necrosis 01/2022 - 09/2019
2	Fibrosis (Cirrhosis) 11/2020 - 09/2017
2	Cicatrix (Scar) 01/2019 - 10/2018
2	Constipation 01/2011 - 11/2009
1	Tuberculosis (Tuberculoses) 04/2024
1	Cognitive Dysfunction 03/2024
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2023
1	Hyperglycemia 12/2023
1	Respiratory Sounds (Crackle) 01/2023
1	Tachypnea 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Cross Infection (Nosocomial Infection) 01/2023
1	Frailty 12/2022
1	Trigeminal Nerve Injuries 01/2022
1	COVID-19 08/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Psoriatic Arthritis 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Dehydration (Water Stress) 12/2020
1	Congenital Abnormalities (Deformity) 08/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Hepatic Encephalopathy 01/2019
1	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2019
1	Neuroma 10/2018
1	Autoimmune Diseases (Autoimmune Disease) 09/2017

Drug/Important Bio-Agent (IBA)

10	tofacitinibIBA 01/2023 - 09/2014
8	Janus Kinase InhibitorsIBA 01/2023 - 09/2014
5	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2017
4	methylnaltrexone FDA Link 11/2011 - 11/2009
4	Pantoprazole (Protonix)FDA LinkGeneric 02/2011 - 12/2003
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 04/2024 - 03/2024
2	COVID-19 VaccinesIBA 01/2023 - 12/2022
2	SolutionsIBA 01/2023 - 08/2021
2	CateninsIBA 01/2022 - 01/2021
2	Creatine Kinase (Creatine Phosphokinase)IBA 09/2021 - 01/2021
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2021
2	N-methyladenosineIBA 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
2	CollagenIBA 01/2019 - 09/2017
2	mu Opioid Receptors (mu Opioid Receptor)IBA 08/2011 - 11/2009
2	Opioid Analgesics (Opioids)IBA 01/2011 - 11/2009
2	Metronidazole (Metric)FDA LinkGeneric 12/2003 - 01/2002
2	Clarithromycin (Biaxin)FDA LinkGeneric 12/2003 - 01/2002
2	Amoxicillin (Wymox)FDA LinkGeneric 12/2003 - 01/2002
1	GoldIBA 04/2024
1	Tuberculin (PPD)IBA 04/2024
1	Small Cytoplasmic RNAIBA 04/2024
1	Interferon-gamma (Interferon, gamma)IBA 04/2024
1	Granzymes (Granzyme)IBA 04/2024
1	Insulin (Novolin)FDA Link 12/2023
1	Long Noncoding RNAIBA 11/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	VaccinesIBA 12/2022
1	Histocompatibility Antigens Class IIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	Prostaglandins AIBA 01/2022
1	6-methyladenineIBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	HydrogelsIBA 01/2021
1	ElectrolytesIBA 12/2020
1	Arecoline (Arecolin)IBA 04/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2019
1	NeurotoxinsIBA 08/2019
1	Rifaximin (L 105)FDA Link 01/2019
1	Lactulose (Duphalac)FDA LinkGeneric 01/2019
1	3-hydroxyphenyltrimethylammoniumIBA 09/2017
1	AutoantibodiesIBA 09/2017
1	AutoantigensIBA 09/2017
1	LigandsIBA 10/2015

Therapy/Procedure

4	Therapeutics 09/2019 - 12/2003
1	Euthanasia (Mercy Killing) 11/2023
1	Hand Hygiene 01/2023
1	Stethoscopes 01/2023
1	Contraindications 12/2022
1	Nerve Transfer 01/2022
1	Oral Surgery (Maxillofacial Surgery) 01/2022
1	Aftercare (After-Treatment) 11/2021
1	Drug Tapering 07/2021
1	Radiotherapy 01/2021
1	Sutures (Suture) 10/2018